Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
QMRO Home
William Harvey Research Institute
Centre for Microvascular Research (CMR)
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
QMRO Home
William Harvey Research Institute
Centre for Microvascular Research (CMR)
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
View/
Open
Published version (2.178Mb)
Volume
215
Pagination
681 - 697
DOI
10.1084/jem.20171288
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Issue
2
ISSN
0022-1007
Metadata
Show full item record
Authors
Tissino, E; Benedetti, D; Herman, SEM; ten Hacken, E; Ahn, IE; Chaffee, KG; Rossi, FM; Dal Bo, M; Bulian, P; Bomben, R
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/72649
Collections
Centre for Microvascular Research (CMR)
[99]
Licence information
Creative Commons License (Attribution 4.0 International)
Copyright statements
© 2018 Tissino et al.
Except where otherwise noted, this item's license is described as Creative Commons License (Attribution 4.0 International)